Tuesday, October 21, 2008

Basilea's Toctino (alitretinoin) Receives Marketing Authorization in France

October 21, 2008 - Basilea Pharmaceutica Ltd. announces that Toctino® (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by the French Health Products Safety Agency....

The details can be read here.

No comments: